AVANOS MEDICAL INC (AVNS) Fundamental Analysis & Valuation

NYSE:AVNS • US05350V1061

13.4 USD
+0.29 (+2.21%)
At close: Mar 11, 2026
13.4 USD
0 (0%)
After Hours: 3/11/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AVNS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

AVNS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of AVNS get a neutral evaluation. Nothing too spectacular is happening here. AVNS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. AVNS Profitability Analysis

1.1 Basic Checks

  • In the past year AVNS was profitable.
  • AVNS had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: AVNS reported negative net income in multiple years.
  • Each year in the past 5 years AVNS had a positive operating cash flow.
AVNS Yearly Net Income VS EBIT VS OCF VS FCFAVNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

  • AVNS's Return On Assets of -6.79% is fine compared to the rest of the industry. AVNS outperforms 65.76% of its industry peers.
  • AVNS has a Return On Equity of -9.37%. This is in the better half of the industry: AVNS outperforms 68.48% of its industry peers.
  • AVNS has a better Return On Invested Capital (1.47%) than 67.93% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for AVNS is significantly below the industry average of 9.15%.
Industry RankSector Rank
ROA -6.79%
ROE -9.37%
ROIC 1.47%
ROA(3y)-14.8%
ROA(5y)-8.25%
ROE(3y)-20.56%
ROE(5y)-11.47%
ROIC(3y)1.82%
ROIC(5y)2.02%
AVNS Yearly ROA, ROE, ROICAVNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30 -40

1.3 Margins

  • AVNS has a Operating Margin of 2.41%. This is in the better half of the industry: AVNS outperforms 67.93% of its industry peers.
  • In the last couple of years the Operating Margin of AVNS has declined.
  • The Gross Margin of AVNS (50.47%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of AVNS has remained more or less at the same level.
Industry RankSector Rank
OM 2.41%
PM (TTM) N/A
GM 50.47%
OM growth 3Y-36.17%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.75%
GM growth 5Y-0.68%
AVNS Yearly Profit, Operating, Gross MarginsAVNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. AVNS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AVNS is destroying value.
  • The number of shares outstanding for AVNS has been increased compared to 1 year ago.
  • The number of shares outstanding for AVNS has been reduced compared to 5 years ago.
  • Compared to 1 year ago, AVNS has an improved debt to assets ratio.
AVNS Yearly Shares OutstandingAVNS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
AVNS Yearly Total Debt VS Total AssetsAVNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 1.17, we must say that AVNS is in the distress zone and has some risk of bankruptcy.
  • AVNS's Altman-Z score of 1.17 is in line compared to the rest of the industry. AVNS outperforms 51.09% of its industry peers.
  • AVNS has a debt to FCF ratio of 2.33. This is a good value and a sign of high solvency as AVNS would need 2.33 years to pay back of all of its debts.
  • AVNS's Debt to FCF ratio of 2.33 is amongst the best of the industry. AVNS outperforms 85.33% of its industry peers.
  • AVNS has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • AVNS's Debt to Equity ratio of 0.12 is fine compared to the rest of the industry. AVNS outperforms 64.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 2.33
Altman-Z 1.17
ROIC/WACC0.15
WACC9.74%
AVNS Yearly LT Debt VS Equity VS FCFAVNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 2.15 indicates that AVNS has no problem at all paying its short term obligations.
  • AVNS has a Current ratio of 2.15. This is comparable to the rest of the industry: AVNS outperforms 40.76% of its industry peers.
  • AVNS has a Quick Ratio of 1.26. This is a normal value and indicates that AVNS is financially healthy and should not expect problems in meeting its short term obligations.
  • AVNS has a Quick ratio of 1.26. This is in the lower half of the industry: AVNS underperforms 66.30% of its industry peers.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.26
AVNS Yearly Current Assets VS Current LiabilitesAVNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AVNS Growth Analysis

3.1 Past

  • AVNS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.40%.
  • The Earnings Per Share has been growing slightly by 3.80% on average over the past years.
  • The Revenue has been growing slightly by 1.95% in the past year.
  • The Revenue has been decreasing by -0.38% on average over the past years.
EPS 1Y (TTM)-25.4%
EPS 3Y-17.1%
EPS 5Y3.8%
EPS Q2Q%-30.95%
Revenue 1Y (TTM)1.95%
Revenue growth 3Y-5.08%
Revenue growth 5Y-0.38%
Sales Q2Q%0.72%

3.2 Future

  • AVNS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.51% yearly.
  • AVNS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.19% yearly.
EPS Next Y8.62%
EPS Next 2Y16.51%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.16%
Revenue Next 2Y3.19%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AVNS Yearly Revenue VS EstimatesAVNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
AVNS Yearly EPS VS EstimatesAVNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. AVNS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.26, which indicates a correct valuation of AVNS.
  • Based on the Price/Earnings ratio, AVNS is valued cheaper than 86.41% of the companies in the same industry.
  • AVNS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.15.
  • With a Price/Forward Earnings ratio of 13.12, AVNS is valued correctly.
  • AVNS's Price/Forward Earnings ratio is rather cheap when compared to the industry. AVNS is cheaper than 89.67% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of AVNS to the average of the S&P500 Index (24.27), we can say AVNS is valued slightly cheaper.
Industry RankSector Rank
PE 14.26
Fwd PE 13.12
AVNS Price Earnings VS Forward Price EarningsAVNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 88.59% of the companies in the same industry are more expensive than AVNS, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, AVNS is valued cheaper than 97.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.46
EV/EBITDA 11.36
AVNS Per share dataAVNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • AVNS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • AVNS's earnings are expected to grow with 16.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.65
PEG (5Y)3.75
EPS Next 2Y16.51%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AVNS Dividend Analysis

5.1 Amount

  • No dividends for AVNS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AVNS Fundamentals: All Metrics, Ratios and Statistics

AVANOS MEDICAL INC

NYSE:AVNS (3/11/2026, 8:04:00 PM)

After market: 13.4 0 (0%)

13.4

+0.29 (+2.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-24
Earnings (Next)05-04
Inst Owners97.21%
Inst Owner Change27.64%
Ins Owners2.94%
Ins Owner Change-0.8%
Market Cap623.10M
Revenue(TTM)701.20M
Net Income(TTM)-72.90M
Analysts43.33
Price TargetN/A
Short Float %6.62%
Short Ratio4.97
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)47.19%
Min EPS beat(2)14.64%
Max EPS beat(2)79.74%
EPS beat(4)4
Avg EPS beat(4)36.78%
Min EPS beat(4)11.11%
Max EPS beat(4)79.74%
EPS beat(8)5
Avg EPS beat(8)16.95%
EPS beat(12)7
Avg EPS beat(12)15.54%
EPS beat(16)10
Avg EPS beat(16)13.47%
Revenue beat(2)2
Avg Revenue beat(2)3.74%
Min Revenue beat(2)1.52%
Max Revenue beat(2)5.97%
Revenue beat(4)4
Avg Revenue beat(4)3.17%
Min Revenue beat(4)1.52%
Max Revenue beat(4)5.97%
Revenue beat(8)4
Avg Revenue beat(8)0.74%
Revenue beat(12)4
Avg Revenue beat(12)-0.83%
Revenue beat(16)4
Avg Revenue beat(16)-4.39%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-36.96%
EPS NQ rev (3m)-36.96%
EPS NY rev (1m)5.37%
EPS NY rev (3m)5.37%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)-0.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.26
Fwd PE 13.12
P/S 0.89
P/FCF 14.46
P/OCF 8.34
P/B 0.8
P/tB 2.35
EV/EBITDA 11.36
EPS(TTM)0.94
EY7.01%
EPS(NY)1.02
Fwd EY7.62%
FCF(TTM)0.93
FCFY6.92%
OCF(TTM)1.61
OCFY11.99%
SpS15.08
BVpS16.74
TBVpS5.71
PEG (NY)1.65
PEG (5Y)3.75
Graham Number18.81
Profitability
Industry RankSector Rank
ROA -6.79%
ROE -9.37%
ROCE 1.86%
ROIC 1.47%
ROICexc 1.63%
ROICexgc 4.36%
OM 2.41%
PM (TTM) N/A
GM 50.47%
FCFM 6.15%
ROA(3y)-14.8%
ROA(5y)-8.25%
ROE(3y)-20.56%
ROE(5y)-11.47%
ROIC(3y)1.82%
ROIC(5y)2.02%
ROICexc(3y)2.02%
ROICexc(5y)2.23%
ROICexgc(3y)5.81%
ROICexgc(5y)7.12%
ROCE(3y)2.3%
ROCE(5y)2.56%
ROICexgc growth 3Y-33.59%
ROICexgc growth 5YN/A
ROICexc growth 3Y-26.31%
ROICexc growth 5YN/A
OM growth 3Y-36.17%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.75%
GM growth 5Y-0.68%
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 2.33
Debt/EBITDA 1.62
Cap/Depr 81.23%
Cap/Sales 4.51%
Interest Coverage 2.6
Cash Conversion 133.87%
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 1.26
Altman-Z 1.17
F-Score6
WACC9.74%
ROIC/WACC0.15
Cap/Depr(3y)52.99%
Cap/Depr(5y)50.85%
Cap/Sales(3y)3.25%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.4%
EPS 3Y-17.1%
EPS 5Y3.8%
EPS Q2Q%-30.95%
EPS Next Y8.62%
EPS Next 2Y16.51%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.95%
Revenue growth 3Y-5.08%
Revenue growth 5Y-0.38%
Sales Q2Q%0.72%
Revenue Next Year2.16%
Revenue Next 2Y3.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-62.19%
EBIT growth 3Y-39.42%
EBIT growth 5YN/A
EBIT Next Year165.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.01%
FCF growth 3Y-15.57%
FCF growth 5YN/A
OCF growth 1Y-25.82%
OCF growth 3Y-6.33%
OCF growth 5YN/A

AVANOS MEDICAL INC / AVNS FAQ

Can you provide the ChartMill fundamental rating for AVANOS MEDICAL INC?

ChartMill assigns a fundamental rating of 4 / 10 to AVNS.


What is the valuation status for AVNS stock?

ChartMill assigns a valuation rating of 6 / 10 to AVANOS MEDICAL INC (AVNS). This can be considered as Fairly Valued.


Can you provide the profitability details for AVANOS MEDICAL INC?

AVANOS MEDICAL INC (AVNS) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for AVNS stock?

The Earnings per Share (EPS) of AVANOS MEDICAL INC (AVNS) is expected to grow by 8.62% in the next year.